拱东医疗：预计2025年全年归属净利润盈利4400万元至5600万元

Core Viewpoint - Gongdong Medical expects a net profit attributable to shareholders of 44 million to 56 million yuan for the full year of 2025, indicating a significant decline in profitability due to various operational challenges and external factors [1]. Group 1: Performance Forecast - The company anticipates a net profit of 44 million to 56 million yuan for 2025 [1]. - The decline in profit is attributed to goodwill impairment, decreased gross margins, and foreign exchange fluctuations [1]. Group 2: Business Impact Factors - Goodwill impairment is expected to be between 24 million to 30 million yuan due to the underperformance of its subsidiary, Trademark Plastics Inc. (TPI), influenced by international trade policies and shipping cost fluctuations [1]. - Gross margin has decreased due to slowed demand for certain products as a result of U.S. tariff policies and domestic medical procurement policies [1]. - Financial expenses have increased due to reduced foreign exchange gains, negatively impacting net profit [1]. Group 3: Financial Results - For the first three quarters of 2025, Gongdong Medical reported a main revenue of 845 million yuan, a year-on-year increase of 1.08% [2]. - The net profit attributable to shareholders for the same period was 71.96 million yuan, reflecting a 49.1% year-on-year decline [2]. - The gross margin for the period was reported at 30.13% [2].